Upon conclusion of this program, participants should be able to:

• Summarize use of warfarin in atrial fibrillation.
• Demonstrate appropriate use of ACE-inhibitors and cardiac resynchronization therapy.
• Analyze new treatments for heart failure including devices.
• Recognize the latest diagnostic and management strategies for ischemic heart disease.

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.